THERAPEUTIC AND/OR PREVENTIVE AGENT FOR DIABETIC ISCHEMIC HEART DISEASE

Details for Australian Patent Application No. 2002237570 (hide)

Owner MITSUBISHI PHARMA CORPORATION

Inventors KITADA, Yoshimi

Pub. Number AU-A-2002237570

PCT Pub. Number WO2002/072099

Priority 2001-71302 14.03.01 JP; 2001-71303 14.03.01 JP

Filing date 12 March 2002

Wipo publication date 24 September 2002

International Classifications

A61K 031/501 - not condensed and containing further heterocyclic rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 031/422 - not condensed and containing further heterocyclic rings

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 003/10 Drugs for disorders of the metabolism

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002237570

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002237571-Linear Oligolactate Ester

2002237569-POSITIVE ELECTRODE ACTIVE MATERIAL AND NONAQUEOUS ELECTROLYTE SECONDARY CELL COMPRISING THE SAME